CNBC
US · 2 hrs ago
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.
Do you trust CNBC?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!